Journal of Pharmacokinetics & Experimental Therapeutics
Open Access
Infliximab Pharmacokinetics
Search results for
Infliximab Pharmacokinetics
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 14
Journal of Pharmacokinetics & Experimental Therapeutics peer review process verified at publons
Indexed In
- RefSeek
- Hamdard University
- EBSCO A-Z
- Publons
- ICMJE
Useful Links
Share This Page
Infliximab Pharmacokinetics
Infliximab is used to treat rheumatoid arthritis, psoriatic arthritis and occasionally severe ankylosing spondylitis. Infliximab pharmacokinetic characteristics were similar in pediatric and adult patients with Crohn's disease or ulcerative colitis.
Journals Related to Infliximab Pharmacokinetics:
Journal of Pharmacokinetics & Experimental Therapeutics, International Journal of Drug Development and Research, Drug Metabolism & Toxicology, Journal of Pharmacokinetics and Biopharmaceutics, Journal of Pharmacokinetics and Pharmacodynamics, Asian Journal of Pharmacodynamics and Pharmacokinetics.
Infliximab Pharmacokinetics
Expert PPTs
- NAGENDRA SASTRY YARLA
Pharmacology
PPT Version | PDF Version
Speaker PPTs
- Rinat Islamov
Pharmacokinetics (PK) of anti-tuberculosis drug (FS-1) on healthy volunteers: results from the phase I trial
PPT Version | PDF Version - Viral Kansara
Ocular melanin modulates pharmacokinetics and drug disposition of therapeutic agents
PPT Version | PDF Version